L2 Asset Management LLC Invests $8.72 Million in Cardinal Health, Inc. $CAH

Key Points

• L2 Asset Management acquired 36,690 Cardinal Health shares worth approximately $8.72 million, making CAH its 24th-largest holding; institutional investors collectively own 87.17% of the stock.
• Cardinal Health reported quarterly EPS of $2.91, beating estimates of $2.42, while revenue rose 5.8% year over year. The company reaffirmed fiscal 2027 adjusted EPS guidance of $12.40–$12.60, and analysts maintain a “Moderate Buy” consensus with an average price target of $266.56.
• Insiders sold 210,271 shares worth roughly $49.6 million over the past three months, including significant sales by the CEO and another insider. Cardinal Health also declared a quarterly dividend of $0.5158 per share, implying an annualized yield of about 0.9%.

L2 Asset Management LLC acquired a new stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 36,690 shares of the company's stock, valued at approximately $8,716,000. Cardinal Health accounts for about 0.9% of L2 Asset Management LLC's investment portfolio, making the stock its 24th largest holding.

A number of other institutional investors also recently added to or reduced their stakes in the business. LWM Advisors Inc. increased its position in Cardinal Health by 4.4% during the 2nd quarter. LWM Advisors Inc. now owns 1,028 shares of the company's stock worth $244,000 after purchasing an additional 43 shares during the period. Kathmere Capital Management LLC lifted its holdings in shares of Cardinal Health by 1.2% in the 1st quarter. Kathmere Capital Management LLC now owns 4,242 shares of the company's stock valued at $896,000 after buying an additional 49 shares during the period. Hillsdale Investment Management Inc. lifted its holdings in shares of Cardinal Health by 0.9% in the 4th quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company's stock valued at $1,184,000 after buying an additional 50 shares during the period. V Square Quantitative Management LLC boosted its stake in shares of Cardinal Health by 2.6% in the first quarter. V Square Quantitative Management LLC now owns 2,002 shares of the company's stock valued at $423,000 after buying an additional 50 shares in the last quarter. Finally, Generali Asset Management SPA SGR grew its holdings in Cardinal Health by 11.0% during the fourth quarter. Generali Asset Management SPA SGR now owns 513 shares of the company's stock worth $105,000 after acquiring an additional 51 shares during the period. Hedge funds and other institutional investors own 87.17% of the company's stock.

Insider Activity

In other Cardinal Health news, insider Michelle D. Greene sold 11,650 shares of the firm's stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $235.72, for a total transaction of $2,746,138.00. Following the completion of the transaction, the insider directly owned 10,330 shares in the company, valued at approximately $2,434,987.60. This trade represents a 53.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Stephen M. Mason sold 35,000 shares of Cardinal Health stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $236.40, for a total transaction of $8,274,000.00. Following the transaction, the chief executive officer owned 18,061 shares of the company's stock, valued at approximately $4,269,620.40. The trade was a 65.96% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 210,271 shares of company stock worth $49,626,657 in the last three months. Company insiders own 0.12% of the company's stock.

Cardinal Health Stock Performance

CAH opened at $232.13 on Tuesday. The company has a market cap of $53.99 billion, a price-to-earnings ratio of 32.11, a PEG ratio of 1.23 and a beta of 0.49. Cardinal Health, Inc. has a one year low of $145.87 and a one year high of $258.30. The business's fifty day moving average is $232.13 and its two-hundred day moving average is $217.96.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, beating analysts' consensus estimates of $2.42 by $0.49. The business had revenue of $63.67 billion during the quarter, compared to analysts' expectations of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.The business's revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the business posted $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, analysts predict that Cardinal Health, Inc. will post 12.54 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be paid a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Thursday, October 1st. Cardinal Health's dividend payout ratio is presently 28.49%.

Key Cardinal Health News

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal Health’s specialty business remains a key growth driver, supporting the case for retaining CAH in portfolios. The company has also issued fiscal 2027 adjusted EPS guidance of $12.40–$12.60, broadly consistent with analyst expectations. Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
• Positive Sentiment: Recent coverage highlights Cardinal Health’s efforts to expand its healthcare reach, potentially creating additional growth opportunities beyond its core pharmaceutical distribution operations. Why Is Cardinal Health Expanding Its Healthcare Reach?
• Positive Sentiment: Cardinal Health’s latest quarterly results provided support for the stock: earnings per share exceeded consensus estimates, while revenue increased year over year. The company’s medical and pharmaceutical services also remain central to its relative performance within the healthcare providers and services group. Winners and Losers of Q2: Cardinal Health vs. Healthcare Providers and Services Stocks

Analyst Upgrades and Downgrades

CAH has been the subject of several research analyst reports. Barclays increased their price objective on Cardinal Health from $258.00 to $275.00 and gave the stock an "overweight" rating in a research report on Thursday, August 13th. Royal Bank Of Canada started coverage on shares of Cardinal Health in a research note on Wednesday, August 19th. They set an "outperform" rating and a $276.00 price target on the stock. Morgan Stanley increased their price target on shares of Cardinal Health from $255.00 to $265.00 and gave the company an "overweight" rating in a report on Wednesday, August 12th. Citigroup raised their price objective on shares of Cardinal Health from $265.00 to $280.00 and gave the company a "buy" rating in a research note on Wednesday, August 12th. Finally, Robert W. Baird boosted their price objective on shares of Cardinal Health from $251.00 to $274.00 and gave the stock an "outperform" rating in a report on Wednesday, August 12th. Sixteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $266.56.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source